Download It

480 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
480
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • World Economic Outlook Database, April 2007 Edition . International Monetary Fund (April 2007).
  • Underlying facts used when forecasting markets for medical devices.
  • Espicom Business Intelligence, June 2007
  • Espicom Business Intelligence, June 2007
  • Espicom Business Intelligence, June 2007
  • Espicom Business Intelligence, June 2007
  • Download It

    1. 1. Medical Devices In Europe Market Overview MassMEDIC October 19, 2007 N. Gerard Zapiain U.S. Department of Commerce
    2. 2. Topics for Presentation <ul><li>What is the European Union? </li></ul><ul><li>Issues on entering the European Union. </li></ul><ul><li>Larger regional markets. </li></ul><ul><li>Emerging markets. </li></ul>
    3. 3. What is the European Union? <ul><li>A political and economic community composed of 27 member states </li></ul><ul><li>Goal: to create a single market to guarantee freedom of movement of people goods, services, and capital between member states </li></ul><ul><li>With over 492 million citizens the EU will generate an estimated GDP of$15.7 trillion in 2007 </li></ul>
    4. 4. What is the European Union? <ul><li>Older members </li></ul><ul><ul><li>Belgium, France, Italy, Luxembourg, Netherlands, Germany, Demark, Ireland, United Kingdom, Greece, Portugal, Spain, Austria, Finland, Sweden </li></ul></ul><ul><li>Newer members </li></ul><ul><ul><li>Cyprus, Czech Republic, Hungary, Latvia, Lithuania, Malta, Poland, Slovakia, Slovenia, Romania, Croatia </li></ul></ul><ul><li>In accession or candidate countries </li></ul><ul><ul><li>Croatia, Turkey, Macedonia, Albania, Bosnia and Herzegovina, Montenegro, Serbia </li></ul></ul>
    5. 5. What is the European Union? <ul><li>Raw Markets </li></ul><ul><ul><li>Croatia </li></ul></ul><ul><ul><li>Serbia </li></ul></ul><ul><ul><li>Albania </li></ul></ul><ul><li>Developing Markets </li></ul><ul><ul><li>Hungary </li></ul></ul><ul><ul><li>Czech Republic </li></ul></ul><ul><ul><li>Poland </li></ul></ul><ul><li>Growing Markets </li></ul><ul><ul><li>Portugal </li></ul></ul><ul><ul><li>Ireland </li></ul></ul><ul><ul><li>Greece </li></ul></ul><ul><li>Mature Markets </li></ul><ul><ul><li>United Kingdom </li></ul></ul><ul><ul><li>Germany </li></ul></ul><ul><ul><li>France </li></ul></ul><ul><ul><li>Italy </li></ul></ul>Typical S-Curve of Expenditures Per Capita Sales Time and Development
    6. 6. What is the European Union? <ul><li>Essentially: </li></ul><ul><ul><li>A great disparity of economic development among members of the European Union </li></ul></ul><ul><ul><li>This contrast will continue into the foreseeable future </li></ul></ul><ul><ul><li>This divergence presents challenges and great opportunities for U.S. exporters of medical devices to the European Union </li></ul></ul>
    7. 7. Issues Upon Entering the European Union <ul><li>Competing goals of cost containment and improve healthcare lead to increased consideration of cost and value of technology </li></ul><ul><li>Customer service increasingly important for sales of higher-technology products </li></ul><ul><li>U.S. exporters must research partners with whom they choose to do business </li></ul><ul><li>Electronic commerce an increasingly important factor in sales </li></ul><ul><li>The number of people 65 years of age and older in Europe is projected to triple in the next generation </li></ul>
    8. 8. Issues Upon Entering the European Union <ul><li>The market for medical devices in France, Germany, Italy, Spain, and the United Kingdom estimated at $51 billion </li></ul><ul><li>Market in these countries growing at 9% annually </li></ul><ul><li>Leading market segments </li></ul><ul><ul><li>Cardiovascular </li></ul></ul><ul><ul><li>General surgery </li></ul></ul><ul><ul><li>Imaging </li></ul></ul><ul><ul><li>In vitro diagnostics </li></ul></ul><ul><ul><li>Ophthalmology </li></ul></ul>
    9. 9. Issues Upon Entering the European Union <ul><li>Leading market segments ( cont’d ) </li></ul><ul><ul><li>Orthopedics </li></ul></ul><ul><ul><li>Neurology </li></ul></ul><ul><ul><li>Urology </li></ul></ul><ul><ul><li>Respiratory </li></ul></ul>
    10. 10. Issues Upon Entering the European Union <ul><li>Factors driving powerful European Union markets </li></ul><ul><ul><li>Vigorous economy </li></ul></ul><ul><ul><li>High level of healthcare spending as a proportion of GDP </li></ul></ul><ul><ul><li>A large population </li></ul></ul><ul><ul><li>An aging population </li></ul></ul><ul><ul><li>High healthcare standards and demand for the latest healthcare technology </li></ul></ul>
    11. 11. Issues Upon Entering the European Union <ul><li>Competitive pressures: The cost and value of technology </li></ul><ul><li>Understanding the value of technology allows full economic and health cost benefits for the medical device to be considered </li></ul><ul><li>Enables competing products to be reviewed on the basis of total cost including purchase price and long-term health costs and benefits </li></ul><ul><li>Ultimately improves the quality of medical care for patients </li></ul>
    12. 12. Issues Upon Entering the European Union <ul><li>Understanding the value of technology </li></ul><ul><ul><li>Includes more than purchase price, and evaluates long term health costs and benefits </li></ul></ul><ul><ul><li>A more expensive purchase price, is often more than offset, by long-term benefits </li></ul></ul><ul><ul><li>Considers the value of long-term health benefits </li></ul></ul>
    13. 13. Issues Upon Entering the European Union <ul><li>Understanding the value of technology through Health Technology Assessment (HTA) </li></ul><ul><li>HTA evaluates the cost and benefits of a medical technology </li></ul><ul><li>Cost impact and benefit cannot always be evaluated in a pre-market setting </li></ul><ul><li>Data must be collected using “real” market experience </li></ul><ul><li>The value of technology takes into account long-term health benefits </li></ul><ul><li>In most cases, once the true value of long-term health benefits are considered a higher technology medical device with a higher purchase price, will actually have a lower total cost </li></ul>
    14. 14. Issues Upon Entering the European Union Common benefits of using higher medical technology Shorter recovery time Eliminates the need for some medical procedures Greater productivity and less “pain and suffering” for the patient Improved “quality of life” for the patient, and quicker return to work Early diagnosis makes treatment less costly and more effective Treats more patients per hour or per day
    15. 15. Issues Upon Entering the European Union <ul><li>The United States Commercial Service: Your foothold in the European Union </li></ul><ul><ul><li>Introductions to qualified buyers and distributors </li></ul></ul><ul><ul><li>Counseling and advocacy through every step of the export process </li></ul></ul><ul><ul><li>World class market research </li></ul></ul><ul><ul><li>Trade events that promote your product or service to qualified buyers </li></ul></ul>
    16. 16. U.S. Medical Device Exports to EU 27 Source: U.S. ITC U.S. Exports in Thousands of Dollars, 2006
    17. 17. U.S. Medical Device Exports to “Eastern Europe” U.S. Exports in Thousands of Dollars, 2006 Source: U.S. ITC
    18. 18. Comparative Growth of Shipments of U.S. Medical Devices to EU 27 and “Eastern Europe” <ul><li>Fact: Growth of shipments from 2005 – 2006 of U.S. medical devices to EU 27 countries: 7.2% </li></ul><ul><li>Fact: Growth in shipments from 2005 – 2006 of U.S. medical devices to “Eastern Europe:” 28.7% </li></ul>Source: U.S. ITC
    19. 19. Larger Regional Markets for U.S. Exporters: Germany <ul><li>Decentralized healthcare system </li></ul><ul><li>German states operate within a loose federal system </li></ul><ul><li>One quarter of the Western European market </li></ul><ul><li>Faces increasing financial challenges: potential health reforms coming </li></ul><ul><li>Highly-competitive market: well-educated healthcare professionals demand latest technology </li></ul><ul><li>Looking at reuse of medical devices </li></ul>
    20. 20. Larger Regional Markets For U.S. Exporters: Netherlands <ul><li>Long history of accessible healthcare </li></ul><ul><li>A mandatory health insurance system </li></ul><ul><li>“ Sneler, Beter” program to improve efficiency in hospitals </li></ul><ul><li>Hopes that this system will bring downward pressure on costs </li></ul><ul><li>Hospitals given grants to develop examples of good practice </li></ul><ul><li>Demand for devices for minimally-invasive surgery should increase </li></ul>
    21. 21. Larger Regional Markets For U.S. Exporters: United Kingdom <ul><li>Expectation to increase healthcare expenditures </li></ul><ul><li>A focus on improving efficiency </li></ul><ul><li>Medical devices that reduce time and overall cost, technologically-advanced or offer overall value of great interest </li></ul><ul><li>Lack of specialists: private organizations coming to manage new independent treatment centers </li></ul><ul><li>Bottom line: receptive to new technology if overall savings are possible </li></ul>
    22. 22. Larger Regional Markets For U.S. Exporters: France <ul><li>Health insurance funds facing deficits, leading to cost pressures on manufacturers </li></ul><ul><li>Rigid control system regulating number of high-cost devices </li></ul><ul><li>Result: number of high-cost devices restricted across the country </li></ul><ul><li>Lengthy bureaucratic procedures and low reimbursement levels </li></ul><ul><li>Reuse of medical devices banned </li></ul>
    23. 23. Emerging European Markets For U.S. Exporters: In General <ul><li>CE Marking the requirement upon accession to European Union </li></ul><ul><li>EU Medical Device Directive transposed into national law </li></ul><ul><li>Streamlining of device registration makes new members of EU appealing markets </li></ul><ul><li>Increased decentralization of healthcare systems replacing aging facilities and equipment </li></ul><ul><li>Continued economic development should support continued demand for imports of higher medical technology </li></ul><ul><li>Greatest U.S. competitor in region: Germany </li></ul>
    24. 24. Emerging European Markets For U.S. Exporters: Poland <ul><li>Among world’s top twenty markets </li></ul><ul><li>Imports a vast majority of its medical devices </li></ul><ul><li>Local production cannot meet demand </li></ul><ul><li>Remarkable growth in imports </li></ul><ul><li>Medical supplies, dental instruments, orthopedics & prosthetics show greatest potential </li></ul>
    25. 25. Emerging European Markets For U.S. Exporters: Czech Republic <ul><li>One of the more developed former Soviet Bloc nations to join the EU </li></ul><ul><li>Normalized regulations (CE Marking) with the rest of EU remarkably quickly </li></ul><ul><li>“ On a mission” to catch up to Germany and Austria </li></ul><ul><li>Some domestic production, but not nearly enough to meet demand </li></ul><ul><li>GDP growth expected to fuel continued demand for imports of higher medical technology </li></ul>
    26. 26. Emerging European Markets For U.S. Exporters: Hungary <ul><li>Largest proportion of citizens over 60 years of age in the region </li></ul><ul><li>Domestic production of low-end medical products, much of which is exported </li></ul><ul><li>On uphill mission to privatize healthcare facilities </li></ul><ul><li>Private investment should lead to greater demand for improved medical equipment </li></ul><ul><li>Continued economic development should support continued demand for imports of higher medical technology </li></ul>
    27. 27. Emerging European Markets For U.S. Exporters: Romania <ul><li>Small private health sector, but growing </li></ul><ul><li>Market size comparable to much larger countries, such as Russia or Ukraine </li></ul><ul><li>Some minor production of medical consumables </li></ul><ul><li>Its failed attempt to accede to the EU in 2004 has spurred Romania to redouble development efforts in the healthcare sector </li></ul><ul><li>Private investment should lead to greater demand for improved medical equipment </li></ul>
    28. 28. In Conclusion <ul><li>The European Union provides a unique patchwork of markets and therefore challenges and possibilities for U.S. exporters of medical devices </li></ul><ul><li>Use of CE Marking in newly-acceded countries simplify regional regulatory requirements </li></ul><ul><li>Different conditions across the region make local intelligence of market factors key to success </li></ul><ul><li>Aging population indicates direction of future medical devices market </li></ul><ul><li>Vibrant economies with high levels of healthcare spending and large populations are fertile ground for medical device producers </li></ul>
    29. 29. N. Gerard Zapiain International Trade Specialist U.S. Department of Commerce International Trade Administration Telephone: 202.482.2410 Fax: 202.482.0975 Email: [email_address] Website: http://www.ita.doc.gov/td/health

    ×